103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
SB2353

 

Introduced 2/10/2023, by Sen. Rachel Ventura

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/302  from Ch. 56 1/2, par. 1302

    Amends the Illinois Controlled Substances Act. Provides that notwithstanding any other provision of the Act to the contrary, including the scheduling of psilocybin as a Schedule I controlled substance, the Department of Financial and Professional Regulation shall authorize the distribution of, and make publicly available, psilocybin for medical, psychological, and scientific studies, research, and other information relating to the safety and efficacy of psilocybin and other entheogens to treat mental health conditions, including, but not limited to, addiction, depression, anxiety disorders, headache disorders, and end-of-life psychological distress. Provides that the Department of Financial and Professional Regulation shall begin receiving applications for the registration of persons to perform the following: (1) manufacturing psilocybin products; (2) operating a service center; (3) facilitating psilocybin services; and (4) testing psilocybin products.


LRB103 28977 RLC 55363 b

 

 

A BILL FOR

 

SB2353LRB103 28977 RLC 55363 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 302 as follows:
 
6    (720 ILCS 570/302)  (from Ch. 56 1/2, par. 1302)
7    Sec. 302. (a) Every person who manufactures, distributes,
8or dispenses any controlled substances; engages in chemical
9analysis, research, or instructional activities which utilize
10controlled substances; purchases, stores, or administers
11euthanasia drugs, within this State; provides canine odor
12detection services; proposes to engage in the manufacture,
13distribution, or dispensing of any controlled substance;
14proposes to engage in chemical analysis, research, or
15instructional activities which utilize controlled substances;
16proposes to engage in purchasing, storing, or administering
17euthanasia drugs; or proposes to provide canine odor detection
18services within this State, must obtain a registration issued
19by the Department of Financial and Professional Regulation in
20accordance with its rules. The rules shall include, but not be
21limited to, setting the expiration date and renewal period for
22each registration under this Act. The Department, any facility
23or service licensed by the Department, and any veterinary

 

 

SB2353- 2 -LRB103 28977 RLC 55363 b

1hospital or clinic operated by a veterinarian or veterinarians
2licensed under the Veterinary Medicine and Surgery Practice
3Act of 2004 or maintained by a State-supported or publicly
4funded university or college shall be exempt from the
5regulation requirements of this Section; however, such
6exemption shall not operate to bar the University of Illinois
7from requesting, nor the Department of Financial and
8Professional Regulation from issuing, a registration to the
9University of Illinois Veterinary Teaching Hospital under this
10Act. Neither a request for such registration nor the issuance
11of such registration to the University of Illinois shall
12operate to otherwise waive or modify the exemption provided in
13this subsection (a).
14    (b) Persons registered by the Department of Financial and
15Professional Regulation under this Act to manufacture,
16distribute, or dispense controlled substances, engage in
17chemical analysis, research, or instructional activities which
18utilize controlled substances, purchase, store, or administer
19euthanasia drugs, or provide canine odor detection services,
20may possess, manufacture, distribute, engage in chemical
21analysis, research, or instructional activities which utilize
22controlled substances, dispense those substances, or purchase,
23store, or administer euthanasia drugs, or provide canine odor
24detection services to the extent authorized by their
25registration and in conformity with the other provisions of
26this Article.

 

 

SB2353- 3 -LRB103 28977 RLC 55363 b

1    (b-5) Notwithstanding any other provision of this Act to
2the contrary, including the scheduling of psilocybin as a
3Schedule I controlled substance, the Department of Financial
4and Professional Regulation shall authorize the distribution
5of, and make publicly available, psilocybin for medical,
6psychological, and scientific studies, research, and other
7information relating to the safety and efficacy of psilocybin
8and other entheogens to treat mental health conditions,
9including, but not limited to, addiction, depression, anxiety
10disorders, headache disorders, and end-of-life psychological
11distress. The Department of Financial and Professional
12Regulation shall begin receiving applications for the
13registration of persons to perform the following:
14        (1) manufacturing psilocybin products;
15        (2) operating a service center;
16        (3) facilitating psilocybin services; and
17        (4) testing psilocybin products.
18    (c) The following persons need not register and may
19lawfully possess controlled substances under this Act:
20        (1) an agent or employee of any registered
21    manufacturer, distributor, or dispenser of any controlled
22    substance if he or she is acting in the usual course of his
23    or her employer's lawful business or employment;
24        (2) a common or contract carrier or warehouseman, or
25    an agent or employee thereof, whose possession of any
26    controlled substance is in the usual lawful course of such

 

 

SB2353- 4 -LRB103 28977 RLC 55363 b

1    business or employment;
2        (3) an ultimate user or a person in possession of a
3    controlled substance prescribed for the ultimate user
4    under a lawful prescription of a practitioner, including
5    an advanced practice registered nurse, practical nurse, or
6    registered nurse licensed under the Nurse Practice Act, or
7    a physician assistant licensed under the Physician
8    Assistant Practice Act of 1987, who provides hospice
9    services to a hospice patient or who provides home health
10    services to a person, or a person in possession of any
11    controlled substance pursuant to a lawful prescription of
12    a practitioner or in lawful possession of a Schedule V
13    substance. In this Section, "home health services" has the
14    meaning ascribed to it in the Home Health, Home Services,
15    and Home Nursing Agency Licensing Act; and "hospice
16    patient" and "hospice services" have the meanings ascribed
17    to them in the Hospice Program Licensing Act;
18        (4) officers and employees of this State or of the
19    United States while acting in the lawful course of their
20    official duties which requires possession of controlled
21    substances;
22        (5) a registered pharmacist who is employed in, or the
23    owner of, a pharmacy licensed under this Act and the
24    Federal Controlled Substances Act, at the licensed
25    location, or if he or she is acting in the usual course of
26    his or her lawful profession, business, or employment;

 

 

SB2353- 5 -LRB103 28977 RLC 55363 b

1        (6) a holder of a temporary license issued under
2    Section 17 of the Medical Practice Act of 1987 practicing
3    within the scope of that license and in compliance with
4    the rules adopted under this Act. In addition to
5    possessing controlled substances, a temporary license
6    holder may order, administer, and prescribe controlled
7    substances when acting within the scope of his or her
8    license and in compliance with the rules adopted under
9    this Act.
10    (d) A separate registration is required at each place of
11business or professional practice where the applicant
12manufactures, distributes, or dispenses controlled substances,
13or purchases, stores, or administers euthanasia drugs. Persons
14are required to obtain a separate registration for each place
15of business or professional practice where controlled
16substances are located or stored. A separate registration is
17not required for every location at which a controlled
18substance may be prescribed.
19    (e) The Department of Financial and Professional
20Regulation or the Illinois State Police may inspect the
21controlled premises, as defined in Section 502 of this Act, of
22a registrant or applicant for registration in accordance with
23this Act and the rules promulgated hereunder and with regard
24to persons licensed by the Department, in accordance with
25subsection (bb) of Section 30-5 of the Substance Use Disorder
26Act and the rules and regulations promulgated thereunder.

 

 

SB2353- 6 -LRB103 28977 RLC 55363 b

1(Source: P.A. 99-163, eff. 1-1-16; 99-247, eff. 8-3-15;
299-642, eff. 7-28-16; 100-513, eff. 1-1-18; 100-759, eff.
31-1-19.)